Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs

Drugs

  • ADHD (35)
  • Anxiety (25)
  • Bipolar Disorder (7)
  • Depression (144)
    • Cardiovascular Disease and Depression (8)
    • Drugs (128)
      • Atypical Antipsychotics (43)
      • Benzodiazepines (36)
      • Bupropion (25)
      • MAOIs (9)
      • SNRIs (47)
      • SSRIs (73)
      • TCAs (30)
      • Typical Antipsychotics (1)
    • Natural Medicines/Supplements (9)
    • Pediatrics (9)
    • Post-Traumatic Stress Disorder (8)
    • Pregnancy (4)
    • Seasonal Affective Disorder (1)
    • Treatment-Resistant Depression (12)
  • Mental Health (24)
  • Resources (127)
  • Schizophrenia (35)
  • Sleep Disorders (54)
  • Substance Use Disorder (160)
121 - 128 of 128 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Oleptro (Trazodone) and Silenor (Doxepin) October 2010
Chart: Comparison of Venlafaxine and Desvenlafaxine August 2010
Chart: State Regulations on Generic Substitution August 2010
Guideline: Health Care Protocol: Prevention of Falls (Acute Care) (2010) April 2010
Guideline: AGS/BGS Clinical Practice Guideline: Prevention of Falls in Older Persons (2010) April 2010
Guideline: Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2010) February 2010
Guideline: Depression and Coronary Disease: Screening, Referral, and Treatment February 2010
Commentary: Antidepressants and Cardiovascular Risk February 2010
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved